Clinical Scorecard: Clinical Guidelines and Definitions for Addressing Weight Recurrence, Partial Response, and Nonresponse After Metabolic and Bariatric Surgery

At a Glance

Key Highlights

• Weight recurrence rates vary widely (9%–91%) due to inconsistent definitions and metrics.
• Partial response and nonresponse are distinct from weight recurrence and require different clinical approaches.
• Current management strategies lack standardized definitions and consensus, leading to variable treatment approaches.

Guideline-Based Recommendations

Diagnosis

• Establish standardized, evidence-informed definitions for weight recurrence, partial response, and nonresponse.
• Use metrics such as nadir weight, percent total weight loss (TWL), excess weight loss (EWL), or percent maximum weight loss to assess postoperative weight changes.
• Adopt consistent terminology: prefer 'weight recurrence' over 'weight regain' and 'partial/nonresponse' over stigmatizing terms like 'weight loss failure'.

Management

• Implement a stepwise treatment model starting with dietary and behavioral interventions.
• Progress to pharmacotherapy if initial interventions are insufficient.
• Consider endoscopic or surgical revision for selected patients based on multidisciplinary evaluation.
• Tailor management strategies according to provider specialty and patient needs.

Monitoring & Follow-up

• Regularly monitor weight trajectory postoperatively, especially within the first 24 months when nadir weight is typically reached.
• Assess for comorbidity recurrence and impact on quality of life and emotional well-being.
• Use consistent weight loss metrics to identify clinically significant weight recurrence.

Risks

• Weight recurrence may lead to comorbidity recurrence, increased healthcare costs, and diminished quality of life.
• Misclassification of weight recurrence, partial response, and nonresponse can delay appropriate management.
• Lack of standardized definitions contributes to inconsistent care and potential suboptimal outcomes.

Patient & Prescribing Data

Patients post-primary metabolic and bariatric surgery experiencing weight recurrence or insufficient weight loss

Pharmacotherapy is recommended as a second-line intervention following behavioral and dietary modifications; surgical revision is reserved for refractory cases.

Clinical Best Practices

• Adopt unified, evidence-based definitions to improve diagnosis and management consistency.
• Use a multidisciplinary approach involving surgeons, dietitians, and nonsurgical providers.
• Apply a stepwise treatment algorithm progressing from lifestyle modification to pharmacotherapy and surgical options as needed.
• Avoid stigmatizing language to support patient engagement and adherence.
• Recognize obesity as a chronic, relapsing disease requiring ongoing multimodal care.

References

• American Society for Metabolic and Bariatric Surgery (ASMBS) Postoperative Weight Recurrence (POWER) Task Force
• Literature review on weight recurrence and bariatric surgery (2020-2023)